Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Developing A Multimodal Precision Medicine Tool to Predict Carotid Plaque Vulnerability
EF 2024-25
Résumé
Stroke costs Canadian economy $3.6 billion per year. Carotid artery disease (CAD), one of the major causes of stroke, arises from plaque development in the arterial wall. Key CAD features such as endothelial cell (EC) activation and monocyte recruitment contribute to plaque instability or vulnerability to rupture. Plaque rupture dislodges atheroembolic material that can further block an end-artery in the brain vasculature resulting in a transient ischemic attack (TIA) (i.e. with recovery) or stroke. Further, EC senescence, driven by EC activation, compromises EC barrier function, exacerbating plaque instability. While surgical intervention is well-established for symptomatic (SM) CAD, managing asymptomatic (ASM) CAD is challenging due to surgery-related stroke risk. Current non-surgical management strategies such as medications and lifestyle changes reduce stroke risk in only some patients. No reliable methods exist to identify ASM CAD patients at risk for plaque rupture, delaying interventions until TIA or stroke occur. This study aims to develop a precision-based approach to predict CAD plaque vulnerability. Specifically, multimodal precision medicine tool will be developed by integrating patient clinical information with select circulating EC senescence-specific proteomics and DNA methylation biomarkers predictive of carotid plaque vulnerability. The significance lies in developing a multimodal, machine-learning driven risk predictive model, offering physicians a tool to identify high-risk CAD patients pre-emptively. Further, the study will provide insight on whether EC senescence can be targeted by novel senotherapeutics to stabilize carotid plaques and reduce stroke risk.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529669
Name
Prajapati Kamalben B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing A Multimodal Precision Medicine Tool to Predict Carotid Plaque Vulnerability
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Athersclerosis; Cardiovascular Disease; Dna Methylation; Endothelial Cell Biology; Precision And Preventative Medicine; Proteomics; Senescence; Stroke
Abstract
Stroke costs Canadian economy $3.6 billion per year. Carotid artery disease (CAD), one of the major causes of stroke, arises from plaque development in the arterial wall. Key CAD features such as endothelial cell (EC) activation and monocyte recruitment contribute to plaque instability or vulnerability to rupture. Plaque rupture dislodges atheroembolic material that can further block an end-artery in the brain vasculature resulting in a transient ischemic attack (TIA) (i.e. with recovery) or stroke. Further, EC senescence, driven by EC activation, compromises EC barrier function, exacerbating plaque instability. While surgical intervention is well-established for symptomatic (SM) CAD, managing asymptomatic (ASM) CAD is challenging due to surgery-related stroke risk. Current non-surgical management strategies such as medications and lifestyle changes reduce stroke risk in only some patients. No reliable methods exist to identify ASM CAD patients at risk for plaque rupture, delaying interventions until TIA or stroke occur. This study aims to develop a precision-based approach to predict CAD plaque vulnerability. Specifically, multimodal precision medicine tool will be developed by integrating patient clinical information with select circulating EC senescence-specific proteomics and DNA methylation biomarkers predictive of carotid plaque vulnerability. The significance lies in developing a multimodal, machine-learning driven risk predictive model, offering physicians a tool to identify high-risk CAD patients pre-emptively. Further, the study will provide insight on whether EC senescence can be targeted by novel senotherapeutics to stabilize carotid plaques and reduce stroke risk.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Prajapati, Kamalben B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~